OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP

OSE Immunotherapeutics SA (DE:6OP) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

6OP Analyst Ratings

Moderate Buy
1Ratings
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
OSE
Immunotherapeutics SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6OP Stock 12 Months Forecast

Average Price Target

€15.00
▲(112.16% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for OSE Immunotherapeutics SA in the last 3 months. The average price target is €15.00 with a high forecast of €15.00 and a low forecast of €15.00. The average price target represents a 112.16% change from the last price of €7.07.
Highest Price Target€15.00Average Price Target€15.00Lowest Price Target€15.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Capital One Financial
€21.01
Buy
197.12%
Upside
Reiterated
On 3/30, OSE reported 2021 results with a net loss of ($18.6M) or (~€16.9M) and ended the period with ~$37.2M (€33.6M) in cash and cash equivalents, derived mainly from partnership milestones and license agreements.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

6OP Financial Forecast

6OP Earnings Forecast
Next quarter’s earnings estimate for 6OP is ― with a range of ― to ―. The previous quarter’s EPS was -€0.11. 6OP beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 46.15% of the time in the same period. In the last calendar year 6OP has Outperformed its overall industry.
Next quarter’s earnings estimate for 6OP is ― with a range of ― to ―. The previous quarter’s EPS was -€0.11. 6OP beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 46.15% of the time in the same period. In the last calendar year 6OP has Outperformed its overall industry.
6OP Sales Forecast
Next quarter’s sales forecast for 6OP is ― with a range of ― to ―. The previous quarter’s sales results were €16.05M. 6OP beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 70.00% of the time in the same period. In the last calendar year 6OP has Outperformed its overall industry.
Next quarter’s sales forecast for 6OP is ― with a range of ― to ―. The previous quarter’s sales results were €16.05M. 6OP beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 70.00% of the time in the same period. In the last calendar year 6OP has Outperformed its overall industry.
6OP Analyst Recommendation Trends
In the current month, 6OP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The 6OP average analyst price target in the past 3 months is €15.00
In the current month, 6OP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The 6OP average analyst price target in the past 3 months is €15.00

6OP Stock Forecast FAQ

What is DE:6OP’s average 12-month price target, according to analysts?
Based on analyst ratings, OSE Immunotherapeutics SA’s 12-month average price target is €15.00.
    What is DE:6OP’s upside potential, based on the analysts’ average price target?
    OSE Immunotherapeutics SA has 112.16% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DE:6OP a Buy, Sell or Hold?
          OSE Immunotherapeutics SA has a conensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is OSE Immunotherapeutics SA’s price target?
            The average price target for OSE Immunotherapeutics SA is €15.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is €15.00 ,the lowest forecast is €15.00. The average price target represents 112.16% Increase from the current price of €7.07.
              What do analysts say about OSE Immunotherapeutics SA?
              OSE Immunotherapeutics SA’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis